CD274 and neoplasm: Before BCG treatment, PD-L1 expression was positive in tumor cells and tumor-infiltrating inflammatory cells within tumor tissues from 2 (9%) and 11 (50%) of 22 BCG-resistant patients, respectively (Table 2).